Neuronetics Stock Shares Owned By Insiders
| STIM Stock | USD 4.66 0.24 5.43% |
Fundamental analysis of Neuronetics allows traders to better anticipate movements in Neuronetics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Neuronetics | Shares Owned By Insiders | Build AI portfolio with Neuronetics Stock |
Neuronetics Company Shares Owned By Insiders Analysis
Neuronetics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Neuronetics Shares Owned By Insiders | 9.48 % |
Most of Neuronetics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neuronetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Neuronetics Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Neuronetics is extremely important. It helps to project a fair market value of Neuronetics Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Neuronetics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Neuronetics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Neuronetics' interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 9.47599999999999% of Neuronetics are shares owned by insiders. This is 37.58% lower than that of the Health Care Equipment & Supplies sector and 38.39% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 6.09% higher than that of the company.
Neuronetics Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neuronetics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neuronetics could also be used in its relative valuation, which is a method of valuing Neuronetics by comparing valuation metrics of similar companies.Neuronetics is currently under evaluation in shares owned by insiders category among its peers.
Neuronetics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Neuronetics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Neuronetics' managers, analysts, and investors.Environmental | Governance | Social |
Neuronetics Fundamentals
| Return On Equity | -1.44 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.54) % | ||||
| Operating Margin | (0.34) % | ||||
| Current Valuation | 353.67 M | ||||
| Shares Outstanding | 66.11 M | ||||
| Shares Owned By Insiders | 9.48 % | ||||
| Shares Owned By Institutions | 62.58 % | ||||
| Number Of Shares Shorted | 4.71 M | ||||
| Price To Book | 8.22 X | ||||
| Price To Sales | 3.27 X | ||||
| Revenue | 74.89 M | ||||
| Gross Profit | 57.41 M | ||||
| EBITDA | (34.56 M) | ||||
| Net Income | (43.73 M) | ||||
| Cash And Equivalents | 73.7 M | ||||
| Cash Per Share | 2.71 X | ||||
| Total Debt | 82.63 M | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 4.02 X | ||||
| Book Value Per Share | 0.54 X | ||||
| Cash Flow From Operations | (31 M) | ||||
| Short Ratio | 4.65 X | ||||
| Earnings Per Share | (1.32) X | ||||
| Target Price | 6.83 | ||||
| Number Of Employees | 716 | ||||
| Beta | 1.85 | ||||
| Market Capitalization | 292.89 M | ||||
| Total Asset | 140.9 M | ||||
| Retained Earnings | (419.79 M) | ||||
| Working Capital | 26.86 M | ||||
| Net Asset | 140.9 M |
About Neuronetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neuronetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neuronetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neuronetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Neuronetics Piotroski F Score and Neuronetics Altman Z Score analysis. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 0.836 | Return On Assets | Return On Equity |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.